We recently reported the existence of a subgroup of patients harboring mutations in the PDGFRA gene (without TERT promoter mutations)6; 11 out of 64 GBM cases (17%) harbored wild-type IDH1 and showed no 1p19q co-deletion (Table S1). The gene discussed is PDGFRA; the disease is glioblastoma.